Annual Cash & Cash Equivalents
$27.37 M
-$57.72 M-67.84%
December 31, 2022
Summary
- As of February 10, 2025, LMNL annual cash & cash equivalents is $27.37 million, with the most recent change of -$57.72 million (-67.84%) on December 31, 2022.
- During the last 3 years, LMNL annual cash & cash equivalents has fallen by -$19.55 million (-41.67%).
Performance
LMNL Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$14.57 M
-$5.35 M-26.84%
June 30, 2023
Summary
- As of February 10, 2025, LMNL quarterly cash and cash equivalents is $14.57 million, with the most recent change of -$5.35 million (-26.84%) on June 30, 2023.
- Over the past year, LMNL quarterly cash and cash equivalents has dropped by -$28.74 million (-66.35%).
Performance
LMNL Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
LMNL Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -67.8% | -66.3% |
| 3 y3 years | -41.7% | -23.4% |
| 5 y5 years | +48.6% | +63.4% |
LMNL Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -67.8% | at low | -82.9% | at low |
| 5 y | 5-year | -67.8% | at low | -84.1% | at low |
| alltime | all time | -67.8% | -99.1% | -84.1% | -100.0% |
Liminal BioSciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $14.57 M(-26.8%) |
| Mar 2023 | - | $19.92 M(-27.2%) |
| Dec 2022 | $27.37 M(-67.8%) | $27.37 M(-8.2%) |
| Sep 2022 | - | $29.80 M(-31.2%) |
| Jun 2022 | - | $43.31 M(-11.6%) |
| Mar 2022 | - | $48.99 M(-42.4%) |
| Dec 2021 | $85.09 M(+140.7%) | $85.09 M(-7.0%) |
| Sep 2021 | - | $91.49 M(+282.6%) |
| Jun 2021 | - | $23.91 M(+40.0%) |
| Mar 2021 | - | $17.08 M(-51.7%) |
| Dec 2020 | $35.35 M(-24.7%) | $35.35 M(+31.3%) |
| Sep 2020 | - | $26.92 M(+41.5%) |
| Jun 2020 | - | $19.03 M(-26.2%) |
| Mar 2020 | - | $25.78 M(-45.1%) |
| Dec 2019 | $46.92 M(+764.8%) | $46.92 M(+2.9%) |
| Sep 2019 | - | $45.60 M(-26.1%) |
| Jun 2019 | - | $61.70 M(+809.7%) |
| Mar 2019 | - | $6.78 M(+25.0%) |
| Dec 2018 | $5.42 M(-70.6%) | $5.42 M(-67.2%) |
| Sep 2018 | - | $16.53 M(+85.3%) |
| Jun 2018 | - | $8.92 M(-17.0%) |
| Mar 2018 | - | $10.74 M(-41.7%) |
| Dec 2017 | $18.42 M(-10.7%) | $18.42 M(-21.1%) |
| Sep 2017 | - | $23.36 M(+112.6%) |
| Jun 2017 | - | $10.99 M(-27.2%) |
| Mar 2017 | - | $15.09 M(-26.9%) |
| Dec 2016 | $20.62 M(-2.3%) | $20.62 M(-30.5%) |
| Sep 2016 | - | $29.66 M(-40.3%) |
| Jun 2016 | - | $49.72 M(+87.3%) |
| Mar 2016 | - | $26.54 M(+25.8%) |
| Dec 2015 | $21.10 M(-9.6%) | $21.10 M(-33.3%) |
| Sep 2015 | - | $31.64 M(-30.7%) |
| Jun 2015 | - | $45.65 M(+182.4%) |
| Mar 2015 | - | $16.16 M(-30.8%) |
| Dec 2014 | $23.35 M(+42.9%) | $23.35 M(+151.0%) |
| Sep 2014 | - | $9.30 M(+387.7%) |
| Jun 2014 | - | $1.91 M(-79.6%) |
| Mar 2014 | - | $9.33 M(-42.9%) |
| Dec 2013 | $16.34 M(+1248.8%) | $16.34 M(+110.0%) |
| Sep 2013 | - | $7.78 M(+42.1%) |
| Jun 2013 | - | $5.48 M(-26.3%) |
| Mar 2013 | - | $7.43 M(+513.3%) |
| Dec 2012 | $1.21 M(+349.6%) | $1.21 M(+113.0%) |
| Sep 2012 | - | $568.80 K(-12.5%) |
| Jun 2012 | - | $650.10 K(+1606.3%) |
| Mar 2012 | - | $38.10 K(-85.9%) |
| Dec 2011 | $269.40 K(+6.9%) | $269.40 K(+149.7%) |
| Sep 2011 | - | $107.90 K(>+9900.0%) |
| Jun 2011 | - | $0.00(-100.0%) |
| Mar 2011 | - | $168.70 K(-33.1%) |
| Dec 2010 | $252.00 K | $252.00 K(-80.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2010 | - | $1.27 M(-68.2%) |
| Jun 2010 | - | $3.99 M(-49.9%) |
| Mar 2010 | - | $7.97 M(+1602.8%) |
| Dec 2009 | $467.90 K(-37.1%) | $467.90 K(-78.5%) |
| Sep 2009 | - | $2.17 M(+335.2%) |
| Jun 2009 | - | $499.80 K(+48.8%) |
| Mar 2009 | - | $335.90 K(-54.9%) |
| Dec 2008 | $744.30 K(-65.7%) | $744.30 K(-81.6%) |
| Sep 2008 | - | $4.04 M(+63.2%) |
| Jun 2008 | - | $2.48 M(+445.3%) |
| Mar 2008 | - | $454.20 K(-79.0%) |
| Dec 2007 | $2.17 M(-87.9%) | $2.17 M(-70.7%) |
| Sep 2007 | - | $7.40 M(+58.8%) |
| Jun 2007 | - | $4.66 M(-60.6%) |
| Mar 2007 | - | $11.83 M(-33.7%) |
| Dec 2006 | $17.86 M(+97.2%) | $17.86 M(+228.0%) |
| Sep 2006 | - | $5.44 M(-45.0%) |
| Jun 2006 | - | $9.91 M(+81.9%) |
| Mar 2006 | - | $5.45 M(-39.9%) |
| Dec 2005 | $9.06 M(+60.8%) | $9.06 M(+53.7%) |
| Sep 2005 | - | $5.89 M(+21.8%) |
| Jun 2005 | - | $4.84 M(+212.5%) |
| Mar 2005 | - | $1.55 M(-72.5%) |
| Dec 2004 | $5.63 M(-69.6%) | $5.63 M(+176.9%) |
| Sep 2004 | - | $2.03 M(-82.8%) |
| Jun 2004 | - | $11.83 M(+219.6%) |
| Mar 2004 | - | $3.70 M(-80.0%) |
| Dec 2003 | $18.52 M(+118.3%) | $18.52 M(+155.9%) |
| Sep 2003 | - | $7.24 M(-27.9%) |
| Jun 2003 | - | $10.04 M(-20.1%) |
| Mar 2003 | - | $12.57 M(+48.1%) |
| Dec 2002 | $8.48 M(+419.9%) | $8.48 M(-50.1%) |
| Sep 2002 | - | $17.01 M(-10.7%) |
| Jun 2002 | - | $19.05 M(+325.4%) |
| Mar 2002 | - | $4.48 M(+174.4%) |
| Dec 2001 | $1.63 M(+7.9%) | $1.63 M(-51.3%) |
| Sep 2001 | - | $3.35 M(+325.3%) |
| Jun 2001 | - | $788.40 K(-48.1%) |
| Mar 2001 | - | $1.52 M(+0.5%) |
| Dec 2000 | $1.51 M(+174.9%) | $1.51 M(-66.6%) |
| Sep 2000 | - | $4.53 M(+571.2%) |
| Jun 2000 | - | $675.00 K(-67.3%) |
| Mar 2000 | - | $2.06 M(+275.3%) |
| Dec 1999 | $550.20 K(-81.1%) | $550.20 K(+61.5%) |
| Sep 1999 | - | $340.70 K(-54.2%) |
| Jun 1999 | - | $744.40 K(+87.2%) |
| Mar 1999 | - | $397.60 K(-86.3%) |
| Dec 1998 | $2.91 M(+111.3%) | $2.91 M(-51.8%) |
| Sep 1998 | - | $6.04 M(+1332.2%) |
| Mar 1998 | - | $421.50 K(+0.7%) |
| Dec 1997 | - | $418.60 K |
| Sep 1997 | $1.38 M | - |
FAQ
- What is Liminal BioSciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Liminal BioSciences?
- What is Liminal BioSciences annual cash & cash equivalents year-on-year change?
- What is Liminal BioSciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Liminal BioSciences?
- What is Liminal BioSciences quarterly cash and cash equivalents year-on-year change?
What is Liminal BioSciences annual cash & cash equivalents?
The current annual cash & cash equivalents of LMNL is $27.37 M
What is the all time high annual cash & cash equivalents for Liminal BioSciences?
Liminal BioSciences all-time high annual cash & cash equivalents is $85.09 M
What is Liminal BioSciences annual cash & cash equivalents year-on-year change?
Over the past year, LMNL annual cash & cash equivalents has changed by -$57.72 M (-67.84%)
What is Liminal BioSciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of LMNL is $14.57 M
What is the all time high quarterly cash and cash equivalents for Liminal BioSciences?
Liminal BioSciences all-time high quarterly cash and cash equivalents is $91.49 M
What is Liminal BioSciences quarterly cash and cash equivalents year-on-year change?
Over the past year, LMNL quarterly cash and cash equivalents has changed by -$28.74 M (-66.35%)